Howell App Flashcards

1
Q

risk factors of prostate cancer

A

Age
Race
Family History
High fat diet

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

shared decision making

A

working with patient to determine outcome

PSA, DRE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

PSA

A

glycoprotein produced only by prostate

prostate specific antigen

tumor marker - increases in levels due to increase in size of prostate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Screening PSA

(sensitive/specific) + when to start

A

SENSITIVE not specific (bc it doesn’t eliminate other possible causes)

Begin checking PSA at 40, or 10 years prior to first degree relative diagnosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

PSA Velocity

A

used as a screening risk

check PSA range over time

Rise of >0.35 ng/mL indicates “rapid” increase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

reasons why PSA could be elevated (5)

A
malignancy
UTI
prostatitis
prostatic trauma
BPH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

abnormal findings on DRE

A

induration or nodularity

prostate should be considered suspicious for prostate cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

limitations of DRE

A

Finger length

body habitus of patient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Prostate Cancer metastasis

A

bone meds to lower back

evaluate with bone scan + Xray

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Histologic type of prostate cancer

A

Adenocarcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Diagnostic analysis of prostate cancer

A
  1. Prostate biopsy via TRUS
  2. MRI
  3. Conventional radionucletide bone scan
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Prostate Biopsy via Transrectal Ultrasound

A

Tumors are hypoechoic on TRUS

TRUS IS NOT first line alone

Expensive, invasive, LOW specificity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Standard method of detecting/proving prostate CA

A

Prostate biopsy via TRUS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

MRI prostate cancer benefits

A

Evaluation of prostate as well as regional lymph nodes

Better at staging than TRUS

Non-invasive, non-radiation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

scale used in staging of prostate cancers

A

Gleason scale

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

stage 1

A

No symptoms, confined to prostate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

stage 2

A

Hard nodule on rectal exam, confined within prostate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

stage 3

A

Spread out of prostate capsule, urinary symptoms appear

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

stage 4

A

Spread beyond prostate to lymph nodes and bones (urine, bone pain, weight loss, fatigue)

20
Q

tx options of prostate cancer

A

active surveillance
radical prostatectomy
radiation therapy
androgen manipulation

21
Q

active surveillance

A

avoid tx in men who will not have disease progression

accurately discuss risks/benefits

(low Gleason score, age and health)

22
Q

radical prostatectomy removes what

A

Removal of entire system (prostate, vas deferens, seminal vesicle)

23
Q

Tx with most proven ability for long term cure for prostate cancer

A

prostatectomy

24
Q

PSA and prostatectomy

A

PSA should drop following surgery

if PSA rises later( >0.2 ng/mL) indicates metastasis or recurrence

PSA is sensitive AND specific here

25
Radical prostatectomy 3 treatment approaches:
Transperineal Open retropubic Laporoscopic
26
Radical prostatectomy in patients with what stage?
Used in patients with LOW stage adjunctive stages 3,4
27
Primary alternative for localized prostate cancer
external beam radiation risk for damage to bladder or rectum
28
Transperineal implantation of radioisotopes + PSA
Seeds Monotherapy or combined PSA can rise for up to 20 months after initiation bc radiation cases inflammation and necrosis
29
Androgen Manipulation and prostate CA what does it do?
Most are hormone dependent Decrease prostate size, improvement in disease symptoms, decline in serum PSA "rapid regression"
30
Androgen Manipulation Long Term Side effects: (7)
Hot flashes loss of libido impotence osteoporosis decreased facial hair loss of muscle mass weight gain
31
BPH V prostate cancer
Prostate CA is most commonly asx and found “incidentally” PC: Elevated Alkaline and Phosphate
32
risk factors of bladder CA
Cigarette smoking Exposure to industrial solvents Dyes MC in men
33
MC presentation of bladder CA
gross or microscopic hematuria (typically painless)
34
tools used to diagnose and stage bladder CA
Cystoscopy Transurethral resection
35
grading of bladder CA
size pleomorphism mitotic rate hyperchromatism
36
categories (depth) of bladder CA
Superficial Invasive Metastatic
37
types of bladder CA
Urothelial (90%) Squamous Adenocarcinoma
38
bulky tumor, hope to reduce size before cystectomy:
neo-adjuvant systemic therapy
39
benefit of immunotherapeutic agents delivered DIRECTLY to bladder
Reduces likelihood of recurrence in those who have undergone complete transurethral resection of dysplastic/CA cells
40
most effective form of intravesical chemo
BCG reduces likelihood of recurrence in those who have undergone complete resection of dysplastic CA cells
41
BCG
basically giving a patient TB still have similar symptoms to other tx mechanisms BUT also TB symptoms
42
types of bladder diversion
Ileal conduit (older, sicker) Continent catheterizable reservoir Orthotopic neobladder (younger patients)
43
extent of bladder CA LE edema and pelvic pressure
CA extends beyond bladder symptoms can be explained by compression of local structures
44
staging of bladder CA based on (2)
extent (depth) into bladder wall presence of regional or distance mets
45
T3 bladder CA tx
radical cystectomy and irradiation or combo of chemo and sx/radiation HIGH risk of progression compared to lower stage